Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Ferraro, M. J. (2000) · Cited by 16,875 · see citing works

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724 · see citing works

National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009

Edwards, J. R., Peterson, K. D., Mu, Y., Banerjee, S. N., Allen‐Bridson, K., Morrell, G. C., Dudeck, M. A., Pollock, D. A., & Horan, T. C. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.10.001 · Cited by 1,257 · see citing works

Epidemiology and Outcomes of Health-care–Associated Pneumonia

Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948 · see citing works

Ventilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria

Trouillet, J., Chastre, J. E., Vuagnat, A., Joly‐Guillou, M., Combaux, D., Dombret, M.-C., & Gibert, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9705064 · Cited by 884 · see citing works

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 419 · see citing works

National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007

Edwards, J. R., Peterson, K. D., Andrus, M. L., Tolson, J. S., Goulding, J. S., Dudeck, M. A., Mincey, R. B., Pollock, D. A., & Horan, T. C. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.04.001 · Cited by 386 · see citing works

Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy

Masterton, R. G., Galloway, A., French, G. L., Street, M. K., Armstrong, J., Brown, E. A., Cleverley, J., Dilworth, P., Fry, C., Gascoigne, A. D., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn162 · Cited by 321 · see citing works

Ventilator-Associated Pneumonia in Neonatal and Pediatric Intensive Care Unit Patients

Foglia, E. E., Meier, M. D., & Elward, A. M. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00041-06 · Cited by 314 · see citing works

A Comparative Analysis of Patients With Early-Onset vs Late-Onset Nosocomial Pneumonia in the ICU Setting

Ibrahim, E., Ward, S., Sherman, G., & Kollef, M. H. (2000) · CHEST Journal · doi:10.1378/chest.117.5.1434 · Cited by 284 · see citing works

Clinical Practice Guidelines for Hospital‐Acquired Pneumonia and Ventilator‐Associated Pneumonia in Adults

Rotstein, C., Evans, G. A., Born, A., Grossman, R. F., Light, R. B., Magder, S. A., McTaggart, B., Weiss, K., & Zhanel, G. G. (2007) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/593289 · Cited by 283 · see citing works

Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia

Chamot, E., Amari, E. B. E., Rohner, P., & van Delden, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2756-2764.2003 · Cited by 219 · see citing works

The Microbiology of Ventilator-Associated Pneumonia

Park, D. R. (2005) · Respiratory Care · doi:10.4187/respcare.05500742 · Cited by 211 · see citing works

Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries

Chawla, R. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.05.011 · Cited by 172 · see citing works

Global Epidemiology of Antimicrobial Resistance among Community-Acquired and Nosocomial Pathogens: A Five-Year Summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)

Jones, R. N. (2003) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2003-37923 · Cited by 167 · see citing works

Using Local Microbiologic Data To Develop Institution-Specific Guidelines for the Treatment of Hospital-Acquired Pneumonia

Beardsley, J. R., Williamson, J., Johnson, J. W., Ohl, C. A., Karchmer, T. B., & Bowton, D. L. (2006) · CHEST Journal · doi:10.1378/chest.130.3.787 · Cited by 140 · see citing works

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)

Hoban, D. J., Biedenbach, D. J., Mutnick, A. H., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00540-0 · Cited by 136 · see citing works

Blood Cultures Have Limited Value in Predicting Severity of Illness and as a Diagnostic Tool in Ventilator-Associated Pneumonia

Luna, C. M., Videla, A. J., Mattera, J., Vay, C. A., Famiglietti, A. M. R., Vujacich, P., & Niederman, M. S. (1999) · CHEST Journal · doi:10.1378/chest.116.4.1075 · Cited by 135 · see citing works

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

Réa-Neto, Á., Niederman, M. S., Lobo, S. M., Schroeder, E., Lee, M., Kaniga, K., Ketter, N., Prokocimer, P., & Friedland, I. R. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802179255 · Cited by 112 · see citing works

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

Tanaseanu, C. M., Bergallo, C., Teglia, O., Jasovich, A., Oliva, M. E., Dukart, G., Dartois, N., Cooper, C. A., Gandjini, H., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.009 · Cited by 112 · see citing works

Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: Results of the Eole study

Montravers, P., Veber, B., Auboyer, C., Dupont, H., Gauzit, R., Korinek, A. M., Mallédant, Y., Martin, C., Moine, P., & Pourriat, J. L. (2002) · Critical Care Medicine · doi:10.1097/00003246-200202000-00017 · Cited by 97 · see citing works

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

Bergallo, C., Jasovich, A., Teglia, O., Oliva, M. E., Lentnek, A. L., de Wouters, L., Zlocowski, J. C., Dukart, G., Cooper, A., & Mallick, R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.09.001 · Cited by 94 · see citing works

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)

Gales, A. C., Sader, H., & Jones, R. N. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00499-6 · Cited by 77 · see citing works

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Jones, R. N., Croco, M. A. T., Kugler, K. C., Pfaller, M. A., & Beach, M. L. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00115-2 · Cited by 61 · see citing works

Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia.

Rello, J. (2005) · Critical Care · doi:10.1186/cc3014 · Cited by 52 · see citing works

Clinical Approach to the Patient With Suspected Ventilator-Associated Pneumonia

Vidaur, L., Sirgo, G., Rodríguez, A. H., & Rello, J. (2005) · Respiratory Care · doi:10.4187/respcare.05500965 · Cited by 48 · see citing works

Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development

Masterton, R. G., Craven, D. E., Rello, J., Struelens, M. J., Møller, J. K., Chastre, J. E., Örtqvist, Å., Cornaglia, G., Lode, H. M., Giamarellou, H., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm176 · Cited by 44 · see citing works

Health care–associated pneumonia: identification and initial management in the ED

Abrahamian, F. M., DeBlieux, P. M. C., Emerman, C. L., Kollef, M. H., Kupersmith, E., Leeper, K. V., Paterson, D. L., & Shorr, A. F. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.03.015 · Cited by 40 · see citing works

Clinical Trial Design for Mild‐to‐Moderate Community‐Acquired Pneumonia—An Industry Perspective

ECHOLS, R. M., Tillotson, G., Song, J., & Tosiello, R. L. (2008) · Clinical Infectious Diseases · doi:10.1086/591399 · Cited by 28 · see citing works

In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia

Bradford, P. A., Petersen, P. J., Tuckman, M., & Jones, C. H. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02063.x · Cited by 17 · see citing works

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192 · see citing works

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892 · see citing works

Klebsiella pneumoniae: Going on the Offense with a Strong Defense

Paczosa, M., & Mecsas, J. (2016) · Microbiology and Molecular Reviews · doi:10.1128/mmbr.00078-15 · Cited by 1,769 · see citing works

Co-infections in people with COVID-19: a systematic review and meta-analysis.

Lansbury, L., Lim, B., Baskaran, V., & Lim, W. S. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.046 · Cited by 1,619 · see citing works

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434 · see citing works

Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae , an urgent threat to public health

Holt, K. E., Wertheim, H. F. L., Zadoks, R. N., Baker, S. G., Whitehouse, C. A., Dance, D. A. B., Jenney, A., Connor, T. R., Hsu, L. Y., Severin, J. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501049112 · Cited by 1,276 · see citing works

Post-stroke infection: A systematic review and meta-analysis

Westendorp, W. F., Nederkoorn, P. J., Vermeij, J., Dijkgraaf, M. G. W., & van de Beek, D. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-110 · Cited by 794 · see citing works

Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria

Nikaido, H., & Pagès, J. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 770 · see citing works

Serratia Infections: from Military Experiments to Current Practice

Mahlen, S. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00017-11 · Cited by 629 · see citing works

Mechanisms of antimicrobial resistance in Gram-negative bacilli

Ruppé, É., Woerther, P., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 500 · see citing works

Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury

Lefrançais, E., Mallavia, B., Zhuo, H., Calfee, C. S., & Looney, M. R. (2018) · JCI Insight · doi:10.1172/jci.insight.98178 · Cited by 472 · see citing works

Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 13: suitability of taxonomic units notified to EFSA until September 2020

(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Álvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., Cesare, A. D., Hilbert, F., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6377 · Cited by 443 · see citing works

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Torres, A., Zhong, N., Pachl, J., Timsit, J., Kollef, M. H., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 443 · see citing works

Pneumonia Classification Using Deep Learning from Chest X-ray Images During COVID-19

Ibrahim, A. U., Özsöz, M., Serte, S., Al-Turjman, F. M., & Yakoi, P. S. (2021) · Cognitive Computation · doi:10.1007/s12559-020-09787-5 · Cited by 443 · see citing works

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

Chang, Y.-T., Lin, C.-Y., Chen, Y.-H., & Hsueh, P.-R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00893 · Cited by 419 · see citing works

The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace

Roca, I., Espinal, P., Vila‐Farrés, X., & Vilà, J. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00148 · Cited by 361 · see citing works

Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen

Koch-Institut, R. (2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-012-1549-5 · Cited by 325 · see citing works

Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options

Cerceo, E. A., Deitelzweig, S. B., Sherman, B. M., & Amin, A. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0220 · Cited by 313 · see citing works

High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia

Chung, D. R., Song, J., Ys, K., Thamlikitkul, V., Huang, S.-G., Wang, H., So, T. M.-K., Yasin, R. M., Hsueh, P., Carlos, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0349oc · Cited by 309 · see citing works

Klebsiella pneumoniae Yersiniabactin Promotes Respiratory Tract Infection through Evasion of Lipocalin 2

Bachman, M. A., Oyler, J. E., Burns, S. H., Caza, M., Lepine, F. L., Dozois, C. M., & Weiser, J. N. (2011) · Infection and Immunity · doi:10.1128/iai.05114-11 · Cited by 308 · see citing works

Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

Adegoke, A. A., Stenström, T. A., & Okoh, A. I. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02276 · Cited by 302 · see citing works

Klebsiella pneumoniae Population Genomics and Antimicrobial-Resistant Clones

Wyres, K. L., & Holt, K. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.007 · Cited by 300 · see citing works

Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

Cillóniz, C., Martín‐Loeches, I., García‐Vidal, C., José, A. S., & Torres, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122120 · Cited by 298 · see citing works

Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management

Barbier, F., Andremont, A., Wolff, M., & Bouadma, L. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f27be · Cited by 281 · see citing works

Corticosteroids for pneumonia

Stern, A., Skalsky, K., Avni, T., Carrara, E., Leibovici, L., & Paul, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007720.pub3 · Cited by 273 · see citing works

Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention

Morello, E., Saussereau, E., Maura, D., Huerre, M., Touqui, L., & Debarbieux, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016963 · Cited by 275 · see citing works

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics

Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 267 · see citing works

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012

Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.007 · Cited by 249 · see citing works

Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis

Li, J., Wang, J., Yang, Y., Cai, P., Cao, J., Cai, X., & Zhang, Y. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00819-1 · Cited by 255 · see citing works

Detection of Pulmonary Infectious Pathogens From Lung Biopsy Tissues by Metagenomic Next-Generation Sequencing

Li, H., Gao, H., Meng, H., Wang, Q., Li, S., Chen, H., Li, Y., & Wang, H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00205 · Cited by 234 · see citing works

A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia

Awad, S. S., Rodríguez, A. H., Chuang, Y.-C., Marjanek, Z., Pareigis, A. J., Reis, G., Scheeren, T., Sanchez, A. S., Zhou, X., Saulay, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu219 · Cited by 232 · see citing works

Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies

Akash, M. S. H., Rehman, K., Fiayyaz, F., Sabir, S., & Khurshid, M. (2020) · Archives of Microbiology · doi:10.1007/s00203-020-01818-x · Cited by 199 · see citing works

Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid

Dickson, R. P., Erb-Downward, J. R., Prescott, H. C., Martinez, F. J., Curtis, J. L., Lama, V. N., & Huffnagle, G. B. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01028-14 · Cited by 176 · see citing works

Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications

Shim, R., & Wong, C. H. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010064 · Cited by 172 · see citing works

State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia

Chong, W. H., Saha, B. K., Ramani, A., & Chopra, A. (2021) · Infection · doi:10.1007/s15010-021-01602-z · Cited by 174 · see citing works

Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia

Bachman, M. A., Lenio, S., Schmidt, L., Oyler, J. E., & Weiser, J. N. (2012) · mBio · doi:10.1128/mbio.00224-11 · Cited by 168 · see citing works

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

Tumbarello, M., PASCALE, G. D., Trecarichi, E. M., Spanu, T., Antonicelli, F., Maviglia, R., Pennisi, M. A., Bello, G., & Antonelli, M. M. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2828-9 · Cited by 167 · see citing works

Ventilator-associated pneumonia: present understanding and ongoing debates

NAIR, G. B., & Niederman, M. S. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3564-5 · Cited by 162 · see citing works

Co-infection in critically ill patients with COVID-19: an observational cohort study from England

Baskaran, V., Lawrence, H., Lansbury, L., Webb, K., Safavi, S., Zainudin, N. I., Huq, T., Eggleston, C., Ellis, J. P., Thakker, C. E., et al. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001350 · Cited by 147 · see citing works

Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis

Weber, G. F., Chousterman, B. G., Hilgendorf, I., Robbins, C. S., Theurl, I., Gerhardt, L. M. S., Iwamoto, Y., Quách, T. D., Ali, M., Chen, J. W., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131471 · Cited by 151 · see citing works

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic‐derived dose justification for phase 3 studies in patients with nosocomial pneumonia

Xiao, A. J., Miller, B. W., Huntington, J. A., & Nicolau, D. P. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.566 · Cited by 149 · see citing works

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)

Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.032 · Cited by 146 · see citing works

STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia

Poe, S. L., Arora, M., Oriss, T. B., Yarlagadda, M., Isse, K., Khare, A., Levy, D. E., Lee, J. S., Mallampalli, R. K., Chan, Y. R., et al. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.62 · Cited by 146 · see citing works

Inhaled Antibiotics for Gram-Negative Respiratory Infections

Wenzler, E., Fraidenburg, D. R., Scardina, T. L., & Danziger, L. H. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-15 · Cited by 145 · see citing works

Murepavadin: a new antibiotic class in the pipeline

Martín‐Loeches, I., Dale, G. E., & Torres, A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1441024 · Cited by 145 · see citing works

Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia

Luyt, C. E., Hékimian, G., Koulenti, D., & Chastre, J. E. (2018) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000526 · Cited by 142 · see citing works

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia

Jean, S., Chang, Y.-C., Lin, W.-C., Lee, W., Hsueh, P., & Hsu, C.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010275 · Cited by 143 · see citing works

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

Yu, X., Robbie, G. J., Wu, Y., Esser, M. T., Jensen, K. M., Schwartz, H. I., Bellamy, T., Hernandez‐Illas, M., & Jafri, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-16 · Cited by 140 · see citing works

The Etiology of Lower Respiratory Tract Infections in People with Diabetes

Klekotka, R., Mizgała-Izworska, E., & Król, W. (2015) · Advances in respiratory medicine · doi:10.5603/piap.2015.0065 · Cited by 137 · see citing works

Evolution and Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in the United Kingdom and Ireland

Moradigaravand, D., Martin, V., Peacock, S. J., & Parkhill, J. (2017) · mBio · doi:10.1128/mbio.01976-16 · Cited by 134 · see citing works

Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults

Ali, O., Yu, X., Robbie, G. J., Wu, Y., Shoemaker, K., Yu, L., DiGiandomenico, A., Keller, A. E., Anude, C., Hernandez‐Illas, M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.004 · Cited by 134 · see citing works

Myeloid-Derived Suppressor Cells in Bacterial Infections

Ost, M., Singh, A., Peschel, A., Mehling, R., Rieber, N. P., & Hartl, D. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00037 · Cited by 132 · see citing works

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia

Peiffer‐Smadja, N., Bouadma, L., Mathy, V., Allouche, K., Patrier, J., Reboul, M., Montravers, P., Timsit, J., & Armand-Lefèvre, L. (2020) · Critical Care · doi:10.1186/s13054-020-03067-2 · Cited by 127 · see citing works

Pharmacokinetic‐Pharmacodynamic Considerations in the Design of Hospital‐Acquired or Ventilator‐Associated Bacterial Pneumonia Studies: Look before You Leap!

Ambrose, P. G., Bhavnani, S. M., Ellis‐Grosse, E. J., & Drusano, G. L. (2010) · Clinical Infectious Diseases · doi:10.1086/653057 · Cited by 126 · see citing works

Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages

Betts, A., Kaltz, O., & Hochberg, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406763111 · Cited by 123 · see citing works

Guidelines for diagnosis and management of community-and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations

Gupta, D., Agarwal, R., Aggarwal, A. N., Singh, N., Mishra, N., Khilnani, G., Samaria, J., Gaur, S., & Jindal, S. (2012) · Lung India · doi:10.4103/0970-2113.99248 · Cited by 121 · see citing works

The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia

Chakraborty, K., Raundhal, M. R., Chen, B. B., Morse, C., Tyurina, Y. Y., Khare, A., Oriss, T. B., Huff, R., Lee, J. S., Croix, C. M. S., et al. (2017) · Nature Communications · doi:10.1038/ncomms13944 · Cited by 120 · see citing works

A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models

Warrener, P., Varkey, R., Bonnell, J. C., DiGiandomenico, A., Camara, M., Cook, K. E., Li, P., Zha, J., Chowdury, P., Sellman, B. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02643-14 · Cited by 119 · see citing works

Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections

Cohen, T. S., Hilliard, J. J., Jones-Nelson, O., Keller, A. E., O’Day, T. L., Tkaczyk, C., DiGiandomenico, A., Hamilton, M. M., Pelletier, M. R., Wang, Q., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9922 · Cited by 118 · see citing works

Dynamics of Lung Defense in Pneumonia: Resistance, Resilience, and Remodeling

Quinton, L. J., & Mizgerd, J. P. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071937 · Cited by 119 · see citing works

Lavender essential oil induces oxidative stress which modifies the bacterial membrane permeability of carbapenemase producing Klebsiella pneumoniae

Yang, S.-K., Yusoff, K., Thomas, W., Akseer, R., Alhosani, M. S., Abushelaibi, A. A., Lim, S. E., & Lai, K. (2020) · Scientific Reports · doi:10.1038/s41598-019-55601-0 · Cited by 117 · see citing works

Cathelicidin-Related Antimicrobial Peptide Is Required for Effective Lung Mucosal Immunity in Gram-Negative Bacterial Pneumonia

Kovach, M. A., Ballinger, M. N., Newstead, M. W., Zeng, X., Bhan, U., Yu, F. X., Moore, B. B., Gallo, R. L., & Standiford, T. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103196 · Cited by 116 · see citing works

Recommendations and guidelines for the treatment of pneumonia in Taiwan

Chou, C.-C., Shen, C., Chen, S., Chen, H.-M., Wang, Y.-C., Chang, W., Chang, Y.-T., Chen, W.-Y., Huang, C.-Y., Kuo, C.-C., et al. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.11.004 · Cited by 115 · see citing works

Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013–14

Shah, N. S., Greenberg, J. A., McNulty, M., Gregg, K., Riddell, J., Mangino, J. E., Weber, D. M., Hebert, C. L., Marzec, N. S., Barron, M. A., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.04.008 · Cited by 112 · see citing works

Microfluidic systems for infectious disease diagnostics

Lehnert, T., & Gijs, M. A. M. (2024) · Lab on a Chip · doi:10.1039/d4lc00117f · Cited by 115 · see citing works

Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China

Yan, Q., Zhou, M., Zou, M., & Liu, W.-E. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2551-2 · Cited by 107 · see citing works

Antibiotic treatment–induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia

Robak, O., Heimesaat, M. M., Kruglov, A., Prepens, S., Ninnemann, J., Gutbier, B., Reppe, K., Hochrein, H., Suter, M., Kirschning, C. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97065 · Cited by 106 · see citing works

The microbiota in pneumonia: From protection to predisposition

Thibeault, C., Suttorp, N., & Opitz, B. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba0501 · Cited by 107 · see citing works

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Housman, S. T., Pope, J. S., Russomanno, J. H., Salerno, E., Shore, E. T., Kuti, J. L., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05354-11 · Cited by 105 · see citing works

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Chastre, J. E., François, B., Bourgeois, M., Komnos, A., Ferrer, R., Rahav, G., Schryver, N. D., Lepape, A., Köksal, İ., Luyt, C. E., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04204-9 · Cited by 106 · see citing works

Prevention of ventilator-associated pneumonia

de Oliveira, J. L. C., Zagalo, C., & Cavaco‐Silva, P. (2014) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2014.01.003 · Cited by 103 · see citing works

Pyoverdine, the Major Siderophore inPseudomonas aeruginosa, Evades NGAL Recognition

Peek, M. E., Bhatnagar, A., McCarty, N. A., & Zughaier, S. M. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/843509 · Cited by 100 · see citing works

Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients

Buehler, P. K., Zinkernagel, A. S., Hofmaenner, D. A., Wendel‐Garcia, P. D., Acevedo, C., Gómez-Mejía, A., Shambat, S. M., Andreoni, F., Maibach, M. A., Bartussek, J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100229 · Cited by 103 · see citing works

Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study

Filipiak, W., Beer, R., Sponring, A., Filipiak, A., Ager, C., Schiefecker, A. J., Lanthaler, S., Helbok, R., Nagl, M., Troppmair, J., et al. (2015) · Journal of Breath Research · doi:10.1088/1752-7155/9/1/016004 · Cited by 97 · see citing works

Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen P seudomonas aeruginosa PAO 1

Betts, A., Vasse, M., Kaltz, O., & Hochberg, M. (2013) · Evolutionary Applications · doi:10.1111/eva.12085 · Cited by 89 · see citing works

What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance

Udy, A. A., Roberts, J. A., Waele, J. J. D., Paterson, D. L., & Lipman, J. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.02.010 · Cited by 89 · see citing works

Rapid syndromic molecular testing in pneumonia: The current landscape and future potential

Poole, S., & Clark, T. W. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.11.021 · Cited by 88 · see citing works

Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009

Lee, K., Kim, M., Kim, J., Hong, H. L., Kang, J. O., Shin, J. H., Park, Y.-J., Yong, D., Jeong, S. H., Chong, Y., et al. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.5.793 · Cited by 86 · see citing works

Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia

El‐Saed, A., Balkhy, H. H., Al‐Dorzi, H. M., Khan, R., Rishu, A. H., & Arabi, Y. M. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.02.004 · Cited by 85 · see citing works

Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update 2017

Dalhoff, K., Abele‐Horn, M., Andreas, S., Deja, M., Ewig, S., Gastmeier, P., Gatermann, S. G., Gerlach, H., Grabein, B., Heußel, C. P., et al. (2018) · Pneumologie · doi:10.1055/s-0043-121734 · Cited by 83 · see citing works

Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers

Tarracchini, C., Milani, C., Longhi, G., Fontana, F., Mancabelli, L., Pintus, R., Lugli, G. A., Alessandri, G., Anzalone, R., Viappiani, A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01176-21 · Cited by 85 · see citing works

European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI

Martín‐Loeches, I., Reyes, L. F., Nseir, S., Ranzani, O., Póvoa, P. M. S. R., Dı́az, E., Schultz, M. J., Rodríguez, A. H., Serrano-Mayorga, C. C., PASCALE, G. D., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07210-9 · Cited by 85 · see citing works

Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Sirota, S. B., Bender, R. G., Dominguez, R.-M. V., Movo, A., Swetschinski, L. R., Araki, D. T., Han, C., Wool, E. E., He, J., Carter, A., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00689-9 · Cited by 102 · see citing works

Real-time PCR as a diagnostic tool for bacterial diseases

Maurin, M. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.53 · Cited by 81 · see citing works

Antimicrobial Treatment of Serratia marcescens Invasive Infections: Systematic Review

Zarić, R. Ž., Zarić, M., Sekulić, M., Zornić, N., Nešić, J., Rosic, V., Vulovic, T. S., Spasić, M., Vuleta, M., Jovanović, J., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12020367 · Cited by 80 · see citing works

Type 3 Fimbriae and Biofilm Formation Are Regulated by the Transcriptional Regulators MrkHI in Klebsiella pneumoniae

Johnson, J. G., Murphy, C. N., Sippy, J., Johnson, T. J., & Clegg, S. (2011) · Journal of Bacteriology · doi:10.1128/jb.00286-11 · Cited by 80 · see citing works

Burden of Adult Community-acquired, Health-care-Associated, Hospital-Acquired, and Ventilator-Associated Pneumonia

Corrado, R. E., Lee, D., Lucero, D. E., Varma, J. K., & Vora, N. M. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.04.162 · Cited by 80 · see citing works

Early ICU Energy Deficit Is a Risk Factor for Staphylococcus aureus Ventilator-Associated Pneumonia

Faisy, C., Llerena, M. C., Savalle, M., Mainardi, J., & Fagon, J.-Y. (2011) · CHEST Journal · doi:10.1378/chest.11-1499 · Cited by 76 · see citing works

Phytosynthesized silver nanoparticles as antiquorum sensing and antibiofilm agent against the nosocomial pathogen Serratia marcescens : an in vitro study

Ravindran, D., Ramanathan, S., Kannappan, A., Jeyaraj, G. P., Shunmugiah, K. P., & Ravi, A. V. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.13728 · Cited by 75 · see citing works

From Klebsiella pneumoniae Colonization to Dissemination: An Overview of Studies Implementing Murine Models

Joseph, L., Merciecca, T., Forestier, C., Balestrino, D., & Miquel, S. (2021) · Microorganisms · doi:10.3390/microorganisms9061282 · Cited by 72 · see citing works

Antibiofilm and Antivirulence Properties of Indoles Against Serratia marcescens

Sethupathy, S., Sathiyamoorthi, E., Kim, Y., Lee, J., & Lee, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.584812 · Cited by 71 · see citing works

Ventilator-associated pneumonia caused by ESKAPE organisms

Sandiumenge, A., & Rello, J. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328351f974 · Cited by 71 · see citing works

Prevalence of Infections and Antimicrobial Resistance of ESKAPE Group Bacteria Isolated from Patients Admitted to the Intensive Care Unit of a County Emergency Hospital in Romania

Bereanu, A. S., Bereanu, R., Mohor, C. I., Vintilă, B. I., Codru, I. R., Olteanu, C., & Sava, M. (2024) · Antibiotics · doi:10.3390/antibiotics13050400 · Cited by 70 · see citing works

Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States

Tabak, Y. P., Merchant, S., Ye, G., Vankeepuram, L., Gupta, V., Kurtz, S., & Puzniak, L. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.06.005 · Cited by 69 · see citing works

Age-related differences in the neutrophil response to pulmonary pseudomonas infection

Chen, M. M., Palmer, J. L., Plackett, T. P., Deburghgraeve, C. R., & Kovacs, E. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.010 · Cited by 68 · see citing works

Bacterial Pathogens of Ventilator Associated Pneumonia in a Tertiary Referral Hospital

Chi, S. Y., Kim, T. O., Park, C. W., Yu, J. Y., Lee, B.-R., Lee, H. S., Kim, Y. I., Lim, S. C., & Kwon, Y. S. (2012) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2012.73.1.32 · Cited by 68 · see citing works

Colonization and immune modulation properties of Klebsiella pneumoniae biofilm-dispersed cells

Guilhen, C., Miquel, S., Charbonnel, N., Joseph, L., Carrier, G., Forestier, C., & Balestrino, D. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0098-1 · Cited by 69 · see citing works

The impact of human vaccines on bacterial antimicrobial resistance. A review

Jansen, K., Gruber, W., Simon, R., Wassil, J., & Anderson, A. S. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01274-z · Cited by 64 · see citing works

Mass gathering medicine (Hajj Pilgrimage in Saudi Arabia): The clinical pattern of pneumonia among pilgrims during Hajj

Shirah, B. H., Zafar, S. H., Alferaidi, O. A., & Sabir, A. M. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.04.016 · Cited by 67 · see citing works

Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Das, S., Li, J., Riccobene, T. A., Carrothers, T. J., Newell, P., Melnick, D., Critchley, I. A., Stone, G. G., & Nichols, W. W. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02187-18 · Cited by 67 · see citing works

Common Bacterial Pathogens and Drug Resistance in Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia

Guo-mi, Z. (2012) · Medical Recapitulate

Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014–2019

Zilberberg, M. D., Nathanson, B. H., Puzniak, L., & Shorr, A. F. (2022) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.464 · Cited by 25 · see citing works

Pathogens distribution and the changes of antibiotic resistance for ventilator-associated pneumonia:a retrospective clinical study

Geng-yu, S. (2008) · Journal of Clinical Pulmonary Medicine

Changes in the prevalence of pathogens causing hospital-acquired bacterial pneumonia and the impact of their antimicrobial resistance patterns on clinical outcomes: A propensity-score-matched study

Choi, M. H., Kim, D., Lee, K. H., Cho, J. H., & Jeong, S. H. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106886 · Cited by 19 · see citing works

Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia

Weber, D. J., Rutala, W. A., Sickbert-Bennett, E. E., Samsa, G. P., Brown, V., & Niederman, M. S. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518460 · Cited by 185 · see citing works